By Michael Laposata MD PhD
The Diagnostic criteria of Care sequence provides universal error linked to diagnoses in medical pathology, utilizing case examples to demonstrate potent research according to present facts and criteria. as well as being useful diagnostic courses, each one quantity demonstrates using caliber coverage and the position of the pathologist in making sure caliber and sufferer protection.
Coagulation Disorders is designed to teach medical pathologists, lab managers, scientific technologists, and citizens the way to stay away from universal blunders in attempt choice and end result interpretation in diagnostic coagulation. using a case-based method, each one bankruptcy includes a concise review of a huge analysis, with a number of illustrative circumstances, after which a listing of instructed criteria of care pertinent to the matter.
simply because it is vital for the practitioner within the analysis of bleeding and thrombotic issues to understand definitely the right plan of action to set up a prognosis or to properly deal with a sufferer, it's both necessary to additionally recognize what to not do. fending off the errors is a serious first step to optimizing sufferer end result and maximizing sufferer safeguard.
positive factors of Coagulation issues comprise:
- An emphasis on opting for demonstrated, evidence-based criteria in coagulation trying out
- Actual case illustrations of often visible blunders in addition to the results of these error on sufferer final result and laboratory administration
- Examples of error which compromise sufferer protection throughout all significant parts of laboratory medication
- Pocket-sized for portability
Read or Download Coagulation Disorders: Diagnostic Standards of Care PDF
Similar hematology books
During this fourth version of the vintage paintings on malignant blood cancers, the group of editors and over a hundred foreign leaders within the box offer a entire textual content at the prognosis and remedy of all hematologic malignancies, either universal and infrequent. This largely revised and up-to-date variation displays the large growth within the technology and therapy of hematologic malignancies throughout the 8 years because the 3rd variation.
2014 BMA scientific booklet Awards hugely counseled in inner medication class! a different scientific concentration makes Consultative Hemostasis and Thrombosis, third version your go-to consultant for speedy, useful solutions on coping with the total variety of bleeding and clotting issues. Emphasizing real-world difficulties and strategies, Dr.
Sjögren’s syndrome is now thought of pivotal within the spectrum of auto-immune issues. It provides in quite a few guises, together with fatigue, aches and pains, nutrients and different asthma and never strangely is often misdiagnosed as, for instance, ‘fibromyalgia, ‘M. E. ’, glandular fever and so forth. It additionally usually overlaps with different auto-immune stipulations reminiscent of hypothyroidism (Hashimotos), Hughes Syndrome and coeliac ailment.
This 3rd version expands upon the function of anticoagulants in scientific perform. furthermore, it summarizes new advancements within the box and offers evidence-based instructions for using anticoagulants in regimen daily perform. The guide of Thromboprophylaxis 3rd version is a key source for all physicians with an curiosity in thromboprophylaxis.
- Advances in Immunology, Volume 86
- Ambulatory Phlebectomy, Second Edition (Basic and Clinical Dermatology)
- Basophil and Mast Cell Degranulation and Recovery (Blood Cell Biochemistry) (Volume 4)
- Fanconi Anemia - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- ABC of Clinical Haematology
- The Blood Group Antigen FactsBook, Third Edition
Extra resources for Coagulation Disorders: Diagnostic Standards of Care
Case with Error A 25-year-old woman with a body mass index of 17 is treated with low molecular weight heparin for deep vein thrombosis. 4 U/mL. The doctor rapidly responds to this value by decreasing the dose of low molecular weight heparin for the next subcutaneous injection. No bleeding complications occur. Explanation and Consequences This is the expected outcome when there is a timely response to an elevated value for anti-factor Xa in a patient being treated with Result Interpretation Mistakes 27 low molecular weight heparin.
The patient does not develop thrombotic complications. Explanation and Consequences It may be difficult to monitor platelet counts in patients being treated with low molecular weight heparin because they are often at home when they are taking the medication. In this case, the patient was in a rehabilitation hospital, and in that setting, assessment of the platelet count was not difficult. The identification of the heparin-induced thrombocytopenia in this patient may have prevented a significant thrombotic event.
The potential consequence is that the doctor may inappropriately adjust the dosage of fondaparinux. 38 4. Patients Being Treated with Fondaparinux RESULT INTERPRETATION MISTAKES Failing to review and act upon a supratherapeutic or subtherapeutic anti-factor Xa value in a patient being treated with fondaparinux in a timely fashion. The potential consequences for patients requiring anticoagulation with fondaparinux whose anti-factor Xa is not in the therapeutic range are bleeding (for anti-factor Xa values above the therapeutic range) and thrombosis (for anti-factor Xa values below the therapeutic range).